
Alphabet is facing federal antitrust litigation in San Francisco over claims that it leverages its dominance of the GPS navigation market—through Google Maps, Waze, and related services—to lock app developers into the “Google ecosystem” and hit them with “egregious” price hikes.
The lawsuit accuses Google of capturing 81% of the market by offering Maps for free, exploiting its data “treasure trove” to cement its monopoly, placing restrictive terms on developers that incorporate its functions, and using other services like search and YouTube to favor Maps by “self-preferencing.”
After Google’s control of the “digital-mapping stack” was complete following its 2013 acquisition of Waze—the only rival offering a full suite of competing services—it began jacking up prices, which have risen by 1,400% since 2018, according to the proposed class action brought by three businesses.
The suit, filed in the U.S. District Court for the Northern District of California, also indirectly challenges the Waze deal—which has recently come under belated scrutiny from antitrust regulators—although it doesn’t seek to unwind the transaction.
The tech giant “bought out one of the few companies in the world making navigable maps while also providing turn-by-turn navigation service” and “bureaucratized” it “into a failing subsidiary” that could be used as a “guinea pig” for monetizing GPS services through advertising, the complaint says.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas